SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.26 |
| Enterprise Value ($M) | 2.21 |
| Book Value ($M) | 0.72 |
| Book Value / Share | 0.16 |
| Price / Book | 4.54 |
| NCAV ($M) | 0.63 |
| NCAV / Share | 0.14 |
| Price / NCAV | 5.15 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -7.85 |
| Return on Assets (ROA) | -1.04 |
| Return on Equity (ROE) | -1.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.80 |
| Current Ratio | 1.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.42 |
| Assets | 1.51 |
| Liabilities | 0.79 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 5.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 71,395 | 356,821 | 20.01 | |
| 592,086 | 1,886,772 | 31.38 | |
| 14,871 | 46,549 | 31.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRPH – ProPhase Labs, Inc. | PRQR – ProQR Therapeutics N.V. |
| PRTG – Portage Biotech Inc. | PTPI – Petros Pharmaceuticals, Inc. |
| PULM – Pulmatrix, Inc. |
Financial data and stock pages provided by
Fintel.io